0.444
price down icon1.99%   -0.009
pre-market  Pre-market:  .44   -0.004   -0.90%
loading
Immunoprecise Antibodies Ltd stock is traded at $0.444, with a volume of 462.94K. It is down -1.99% in the last 24 hours and down -14.78% over the past month. ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
See More
Previous Close:
$0.453
Open:
$0.45
24h Volume:
462.94K
Relative Volume:
0.08
Market Cap:
$20.32M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-0.9363
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
-12.60%
1M Performance:
-14.78%
6M Performance:
-25.89%
1Y Performance:
-77.46%
1-Day Range:
Value
$0.4327
$0.4523
1-Week Range:
Value
$0.4316
$0.534
52-Week Range:
Value
$0.3248
$2.4299

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Name
Immunoprecise Antibodies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
101
Name
Twitter
Name
Next Earnings Date
2024-09-16
Name
Latest SEC Filings
Name
IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
0.444 20.32M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.58 118.84B 11.02B -535.60M -1.35B -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
674.27 73.71B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
651.34 39.58B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.89 34.17B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.78 29.44B 3.30B -501.07M 1.03B -2.1146

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-22 Initiated H.C. Wainwright Buy
Oct-25-21 Initiated The Benchmark Company Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

pulisher
Feb 07, 2025

ImmunoPrecise Antibodies Ltd (IPA) Shares Up Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

ImmunoPrecise Antibodies Ltd (IPA) presents a great opportunity, but the stock is slightly overvalued - US Post News

Feb 05, 2025
pulisher
Feb 03, 2025

ImmunoPrecise Antibodies Boosts Financial Position Through Successful Capital Initiatives - TipRanks

Feb 03, 2025
pulisher
Jan 28, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 3.9% – Here’s Why - Defense World

Jan 28, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech Innovation - Insider Monkey

Jan 27, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture - The Globe and Mail

Jan 27, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies Strengthens Financial Position with Strategic Capital Initiatives - TipRanks

Jan 27, 2025
pulisher
Jan 26, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 By Investing.com - Investing.com Canada

Jan 24, 2025
pulisher
Jan 23, 2025

Immunoprecise uses AI to develop new class of GLP-1 therapies - BioWorld Online

Jan 23, 2025
pulisher
Jan 23, 2025

ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Stock Traders Buy High Volume of ImmunoPrecise Antibodies Call Options (NASDAQ:IPA) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

What's Going On With ImmunoPrecise Antibodies Stock Wednesday? - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

ImmunoPrecise Antibodies Leverages AI for Next-Gen Diabetes Treatment - TipRanks

Jan 22, 2025
pulisher
Jan 22, 2025

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment - Business Wire

Jan 22, 2025
pulisher
Jan 22, 2025

This Biotech Soared On Wednesday Following AI-Related Announcement - The Globe and Mail

Jan 22, 2025
pulisher
Jan 20, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Launches AI-Powered Drug Discovery Pipeline, Revolutionizing Therapeutic Development with LENSai™ Platform - Insider Monkey

Jan 20, 2025
pulisher
Jan 20, 2025

10 Trending AI Stocks on Latest News and Ratings - Insider Monkey

Jan 20, 2025
pulisher
Jan 17, 2025

ImmunoPrecise launches AI-driven drug discovery pipeline - Investing.com India

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise launches AI-driven drug discovery pipeline By Investing.com - Investing.com Canada

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise Antibodies Launches AI-Powered Drug Discovery Platform - TipRanks

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation - Business Wire

Jan 17, 2025
pulisher
Jan 17, 2025

Even With A 30% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely - Simply Wall St

Jan 17, 2025
pulisher
Jan 17, 2025

ImmunoPrecise Launches Groundbreaking AI Platform LENSai for Revolutionary Drug Discovery - StockTitan

Jan 17, 2025
pulisher
Jan 04, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Up 15.5% – What’s Next? - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

ImmunoPrecise Antibodies Announces CFO Resignation - TipRanks

Jan 03, 2025
pulisher
Jan 02, 2025

ImmunoPrecise Antibodies finance chief to step down - MSN

Jan 02, 2025
pulisher
Jan 02, 2025

ImmunoPrecise Antibodies announces resignation of CFO - Yahoo Finance

Jan 02, 2025
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies Ltd. Announces the Resignation of Kristin Taylor as Chief Financial Officer, Effective January 16, 2025 - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies CFO Resignation and Succession - TipRanks

Dec 31, 2024
pulisher
Dec 31, 2024

ImmunoPrecise Antibodies CFO Kristin Taylor Announces Resignation, Will Transition Through January 2025 - StockTitan

Dec 31, 2024
pulisher
Dec 31, 2024

IPA Announces Resignation of Chief Financial Officer - Business Wire

Dec 31, 2024
pulisher
Dec 23, 2024

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases - The Globe and Mail

Dec 23, 2024
pulisher
Dec 19, 2024

ImmunoPrecise Antibodies to Present at Microcap Conference 2025: AI-Driven Biotech Showcase - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

ImmunoPrecise Antibodies to Showcase at Microcap Conference - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

IPA to Present at The Microcap Conference 2025 - Business Wire

Dec 19, 2024
pulisher
Dec 14, 2024

HC Wainwright Has Optimistic Outlook of IPA Q3 Earnings - Defense World

Dec 14, 2024

Immunoprecise Antibodies Ltd Stock (IPA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.67
price down icon 1.17%
$21.82
price up icon 11.50%
$4.60
price down icon 0.65%
$370.44
price down icon 0.08%
biotechnology ONC
$225.49
price up icon 0.98%
$122.78
price up icon 9.73%
Cap:     |  Volume (24h):